Business Strategies
As a leading specialty pharmaceutical company, Barr Pharmaceuticals
focuses its resources on three principal strategies:
>
developing and marketing selected generic
pharmaceuticals;
>
developing and marketing proprietary
pharmaceuticals; and
>
pursuing development and marketing of
biopharmaceuticals.
To support
its business strategies, the Company continually evaluates acquisition
opportunities to strengthen its product portfolio and help grow
its generic business. Barr regularly evaluates opportunities
such as strategic product acquisitions, new technology arrangements
including new technology platforms, and corporate mergers and
acquisitions.
Product Guide 
